| Literature DB >> 34967891 |
Mei Wang1,2,3, Ling Zeng4, Ping Su4, Ling Ma1,3, Ming Zhang1,3, Yuan Zhen Zhang1,3.
Abstract
BACKGROUND: Autophagy is an intracellular catabolic process of degrading and recycling proteins and organelles to modulate various physiological and pathological events, including cell differentiation and development. Emerging data indicate that autophagy is closely associated with male reproduction, especially the biosynthetic and catabolic processes of sperm. Throughout the fate of sperm, a series of highly specialized cellular events occur, involving pre-testicular, testicular and post-testicular events. Nonetheless, the most fundamental question of whether autophagy plays a protective or harmful role in male reproduction, especially in sperm, remains unclear. OBJECTIVE AND RATIONALE: We summarize the functional roles of autophagy in the pre-testicular (hypothalamic-pituitary-testis (HPG) axis), testicular (spermatocytogenesis, spermatidogenesis, spermiogenesis, spermiation) and post-testicular (sperm maturation and fertilization) processes according to the timeline of sperm fate. Additionally, critical mechanisms of the action and clinical impacts of autophagy on sperm are identified, laying the foundation for the treatment of male infertility. SEARCHEntities:
Keywords: autophagy / hypothalamic-pituitary-testis axis / spermatogenesis / acrosome biogenesis / acrosome reaction / paternal mitochondria elimination / ectoplasmic specialisation / sperm maturation / erectile dysfunction / fertilisation
Mesh:
Year: 2022 PMID: 34967891 PMCID: PMC8889000 DOI: 10.1093/humupd/dmab043
Source DB: PubMed Journal: Hum Reprod Update ISSN: 1355-4786 Impact factor: 15.610
Figure 1.The developmental history and types of autophagy. (a) Developmental history of autophagy. In 1962, autophagy originated from an observation that increased lysosomes migrated toward organelles in response to the addition of glucagon in rat liver cells. In 1963, a detailed ultrastructure of ‘focal cytoplasmic degradation’ was described; the term ‘autophagy’ was proposed as a part of lysosomal function. In the 1990s, autophagy started to be investigated extensively due to starvation-induced non-selective autophagy, followed by selective autophagy. In the early 21st century, autophagy was demonstrated as one of the repair mechanisms as damaged organelles, membranes, and proteins were degraded for generating energy and building new proteins and membranes through autophagy-mediated cellular metabolism. In 2005 and 2014, autophagic cell death was identified as a novel way of programmed cell death (PCD). (b) Types of autophagy. 1. Macroautophagy is a conserved dynamic process, which consists of induction (phagophore formation), nucleation, elongation, closure (autophagosome formation), fusion (autophagosome and lysosome into autophagolysosome) and degradation, thus degrading organelles and proteins for the synthesis of new macromolecules or as a source of energy. Involved signaling pathways are as follows: I. Induction: mTORC1 inhibits ULK complex, which comprises ULK1/2 (also named ATG1), RB1CC1 (also named ATG17), ATG13 and ATG101, leading to the translocation of the complex to the phagophore and initiating the autophagy. II. Nucleation: ULK complex activates PI3K complex (BECN1-VPS34-VPS15-ATG14) by the phosphorylation of AMBRA1 and BECN1, generating phosphatidylinositol 3-phosphate (PI3P) on phagophore membrane. PI3P recruits WIPI, DFCP1 and ATG2 to promote autophagosome formation. III. Elongation: it is regulated by two conjugated systems of LC3-II (also named ATG8) and ATG12–ATG5–ATG16 complex. LC3 precursor is hydrolyzed by ATG4 to form LC3-I, which interacts with ATG7 and ATG3, forming LC3-II (also known as LC3-PE). IV. Closure: LC3-II and ESCRT regulate the closure of phagophore, thus facilitating the autophagosome formation. V. Fusion and degradation: after closure, the mature autophagosome and a lysosome fuse into an autophagolososome, which degrades the dispensable organelles and proteins. Autophagosomal SNAP receptors (STX17, YKT6) interact with SNAP29, which binding to lysosomal SNAP receptors (VAMP7, VAMP8 and STX7), together with HOPS complex, EPG5 and PLEKHM1 promoting the fusion. Due to the difference of destructive targets, macroautophagy is divided into non-selective autophagy targeting bulk cytosol and selective autophagy targeting specific cargos, such as mitochondrion, endoplasmic reticulum, lipid, peroxisome, ribosome, aggresome and ferritin. The specific cargo directly recognizes LC3 or indirectly recognizes LC3 through ubiquitin with specific cargo adapters, such as general adaptors (p62, NBR1, OPTN, NDP52, TAX1BP1), mitophagy adapters (NIX, BNIP3, FUNDC1, PHB2, BCL2-L-13, FKBP8), reticuphagy adapters (FAM134B, RTN3L, CCPG1, SEC62, ATL3, TEX264), ribophagy adapter (NUFIP1), aggrephagy adaptors (ALFY, UBQLN2), and ferritinophagy adaptor (NCOA4). 2. In chaperone-mediated autophagy (CMA), proteins carrying KFERQ motif are recognized by the Hsp70 chaperone, which interacts with lysosome membrane protein LAMP-2A, leading the translocation of the bound protein into the lysosome and degradation. 3. Microautophagy is characterized by the direct engulfment of cytoplasmic material into the lysosome through invagination and pinching off.
Autophagy-related genes KD/KO in the mammalian testis/testicular cells.
| Autophagy- related gene | Autophagy- related process | KD/KO model | Fertility | Phenotype | Functions in testis | Reference(s) |
|---|---|---|---|---|---|---|
|
| ||||||
|
| Phagophore formation | cKO in germ cells | Subfertile | Induce sperm counts and motility reduction, misshapen sperm heads and tails, abnormal mitochondria and acrosome distribution | Elongating spermatid development, sperm individualization during spermiogenesis |
|
| cKO in Sertoli cells | Infertile | Disrupt cytoskeleton structures and ectoplasmic specialization assembly | Ectoplasmic specialization assembly |
| ||
| cKO in Leydig cells | Subfertile | Suppress testosterone synthesis, affect sexual behavior | Testosterone synthesis |
| ||
|
| Phagophore, autophagosome formation | cKO in germ cells | Subfertile | Inhibit spermatozoa flagella biogenesis and cytoplasm removal | Spermatozoa flagella biogenesis and cytoplasm removal during spermiogenesis |
|
| cKO in germ cells | Infertile | A defect in acrosome biogenesis | Acrosome biogenesis |
| ||
| cKO in Sertoli cells | Subfertile | Disrupt cytoskeleton structures and ectoplasmic specialization assembly | Ectoplasmic specialization assembly |
| ||
| cKO in Leydig cells | Subfertile | Suppress testosterone synthesis, affect sexual behavior | Testosterone synthesis |
| ||
| KD in rat primary Leydig cells | – | Suppress testosterone biosynthesis | Testosterone biosynthesis |
| ||
| KD in rat primary Sertoli cells | – | Promote androgen-binding protein expression | Autophagic clearance of androgen-binding protein |
| ||
|
| Phagophore formation | KD in TM3 mouse Leydig cells | – | Decrease testosterone production | Steroidogenesis |
|
|
| Lysosomal biogenesis | KD in GC-1 mouse spg cells | – | Not affect spermatogonial differentiation, but significantly reduce cell migration in GC-1 cells | Spermatogonial cell migration |
|
|
| Phagophore, autophagosome, autolysosome formation | No KD/KO in testis | ||||
|
| ||||||
|
| HSC70 substrate | KO mice | Infertile | Impair spermiogenesis, meiosis, induce polyploid spermatids | Spermiogenesis |
|
| KO mice | Infertile | Disruptions in spermatogenesis that begin during prepubertal testicular development, and continue into adulthood, often resulting in loss of germ cells to the point of Sertoli cell-only syndrome. | Chromatin condensation and acrosome development |
| ||
| cKO in germ cells | Infertile | Induce sperm counts reduction, misshapen sperm | Spermiogenesis |
| ||
|
| Chaperon-mediated autophagy | No KD/KO in testis | ||||
|
| ||||||
|
| Mitophagy | No KD/KO in testis | ||||
|
| ||||||
|
| mTORC1/mTORC2 component | KD in rat primary Sertoli cells | – | Reduce androgen- binding protein expression | Autophagic clearance of androgen binding protein |
|
| cKO in Sertoli cells | Infertile | Induce testicular atrophy, loss of Sertoli cell polarity, germ cell premature release/apoptosis, loss of pachytene spermatocytes and spermatids, sperm abnormalities | Sertoli cell polarity, germ cell development through the pachytene spermatocyte stage |
| ||
| cKO in germ cells | Infertile | Result in smaller testis and no sperm, impair spermatogonial proliferation | Spermatogonial proliferation and differentiation |
| ||
| cKO in germ cells | Subfertile | Induce age-dependent perturbation of testicular development, diminished spermatogonial pool and germ cell population | Spermatogonial proliferation and differentiation |
| ||
|
| mTORC1 component | cKO in germ cells | Infertile | Block spermatogonia proliferated and differentiation, result in Sertoli cell-only testes by adulthood | SSCs pool maintenance |
|
| cKO in germ cells | Infertile | Induce smaller testes and infertility | Meiotic arrest and sex chromosomes silence |
| ||
| cKO in germ cells | Infertile | Impair spermatogenesis and induce progressive loss of spermatogonia | SSCs proliferation |
| ||
| cKO in Sertoli cells | Infertile | Cause severe tubular degeneration in the neonatal testis, azoospermia in adult mice with disruption of cytoskeletal organization | Sertoli cell cytoskeletal organization and polarity |
| ||
|
| mTORC2 component | cKO in germ cells | Sterile | Impair spermatogonial differentiation potential, cell–cell junctions, BTB dynamics, and spermiogenesis | Spermatogonial differentiation and intercellular adhesion |
|
|
| Upstream of mTOR | KD in rat primary Sertoli cells | – | Disrupt Sertoli cell tight junction barrier | BTB function |
|
|
| Upstream of mTORC1 | KD in rat primary Sertoli cells | – | Perturb F-actin and MTs organization in Sertoli cells | Sertoli cell BTB dynamics |
|
|
| mTORC1 inhibitor | cKO in germ cells | Subfertile | Induce testicular developmental defects, partial spermatogenic arrest, excessive germ cell loss, sperm count reduction and subfertility; mTORC1 activation promotes spermatogonial differentiation at the expense of germline maintenance | Spermatogonial differentiation |
|
|
| Downstream of mTORC1 | No KD/KO in testis | ||||
|
| ULK complex | KD in goat primary Sertoli cells | – | Decrease cell viability and expressions of goat Sertoli cell marker genes ( | Sertoli cell function, viability |
|
|
| ULK complex | KD in swine Sertoli cells | – | Inhibit swine Sertoli cell autophagy | Sertoli cell function |
|
|
| ULK complex | No KD/KO in testis | ||||
|
| VPS34 complex, autophagosome formation | No KD/KO in testis | ||||
ABP, sex hormone binding globulin; AMH, anti-Mullerian hormone; BTB, blood-testis barrier; cKO, conditional knockout; FASL, Fas ligand; GATA4, GATA binding protein 4; GC-1 cells, mouse spermatogonial cell lines; KD, knockdown; KO, knockout; MT, microtubule; mTOR, mammalian target of rapamycin; SCC, spermatogonia stem cell; TM3 cells, mouse Leydig cell lines; ULK1, Unc-51 like autophagy activating kinase.
Figure 2.The process of spermatogenesis. The entire process of spermatogenesis can be divided into three stages as follows: Spermatocytogenesis: spermatogonia undergo mitosis to develop into primary spermatocytes; Spermatidogenesis: the primary spermatocytes undergo meiosis I to form secondary spermatocytes, which divide into haploid round spermatids via meiosis II; and spermiogenesis: round spermatids are differentiated into the elongated spermatids and then spermatozoa.
The functions of autophagy in mammalian systems.
| Organs | Functions | Autophagy-related gene or protein changes | Selected references |
|---|---|---|---|
|
| Testosterone biosynthesis | Atg5/7↓ |
|
| Acrosome biogenesis | Atg7, Sirt1, Tbc1d20↓ |
| |
| Spermiogenesis | Atg7↓ |
| |
| Ectoplasmic specialization | Atg5/7↓ |
| |
| Androgen binding protein metabolism | Atg7, mTOR↓ |
| |
|
| Preventing excessive loss of oocytes in the neonatal ovaries | Beclin 1, Atg7↓ |
|
| Promoting progesterone synthesis | Beclin 1↓ |
| |
| Follicle atresia | LC3-II/LC3-I↑ |
| |
|
| Preimplantation development/protein synthesis | Atg5, Beclin 1↓ |
|
| Nervous system development | Ambra1↓ |
| |
| Preventing neonatal lethality/survival during neonatal starvation | Atg3/5/7/8/9a/16L1↓ |
| |
|
| Preventing placental infection and preterm labor | LC3-II/LC3-I, Atg4/7/16L1↑ and p62↓ |
|
|
| Constitutive turnover of cytoplasmic components | Atg7↓ |
|
|
| Regulating food intake and energy balance | Atg7↓ |
|
| Metabolic regulation/central control of feeding, energy and body weight balance | Atg5/7, LC3-II/LC3-I↓ |
| |
| Prevent neurodegenerative disease | Atg5/7, LC3-II/LC3-I, Atg12↓ |
| |
| Axonal homeostasis | Atg5/7↓ |
| |
| Atg9, ULK1, Beclin 1, LC3-II↓ |
| ||
|
| Maintaining cardiomyocyte size and global cardiac structure and function/adaption to hemodynamic stress | Atg5/7, LC3-II/LC3-I↓ and p62↑ |
|
| Angiogenesis | Beclin 1, Atg5, LC3-II/LC3-I ↓ and p62↑ |
| |
|
| Preserving muscle mass and to maintain myofiber integrity | Atg7↓ |
|
|
| Maintaining Paneth cells function | Atg5/16L1↓ |
|
|
| Maintaining pancreatic β-cell volume and function | Atg7↓ |
|
| Adaption to high-fat diet | Atg7↓ |
| |
|
| Maintaining podocyte integrity | Atg5↓ |
|
| Maintaining proximal tubule cell homeostasis and protecting against ischemic injury | Atg5↓ |
|
mTOR, mammalian target of rapamycin.
Autophagy in environmental toxicants-induced mammalian testicular cell injury.
| Toxin (environmental source) | Affected testicular cell | Autophagy- related gene or protein changes | Resulted in testicular pathology | In human/animal/ cell model | Reference |
|---|---|---|---|---|---|
|
| Leydig cells | LC3-II, Atg5, Beclin 1↑ | Decrease serum testosterone, induce oxidative stress and cell apoptosis | Kunming mice |
|
| GC-1 cells | LC3-II, Beclin 1, Atg5, LC3-II/ LC3-I↑ | Induce oxidative stress, increase autophagic vacuoles number | Mouse GC-1 spg cell line |
| |
|
| Leydig cells and sperm | Beclin 1, Atg5/12, LC3↑ | Induce spermatogenic epithelium atrophy, germ cell loss, changes of hormones in serum and oxidative stress | Prepubertal Sprague Dawley rats |
|
|
| GC-1 cells | Atg3, Atg5, p62, LC3-II/LC3-I, Beclin 1, Atg5, p62↑ | Alter cell viability and morphology, induce oxidative stress-mediated mitochondrial dysfunction | Mouse GC-1 spg cell line |
|
|
| Leydig cells and sperm |
LC3, Beclin 1, Atg5, p62↑ p-mTOR/mTOR↓ | Reduce serum testosterone level, impair sperm, induce the atrophic seminiferous tubules, vacuole-like changes of spermatogenic epithelium, and oxidative stress | Kunming mice |
|
| Leydig cells | LC3, Beclin 1, p62↑ | lower serum T, LH and FSH levels, reduce Leydig cell number | Sprague Dawley rats |
| |
|
| Leydig cells | LC3-II, Atg5↑ | Inhibit cell proliferation and vitality | MLTC-1 cell line |
|
|
| Leydig TM3 cells | LC3-II/LC3-I, Atg5, Beclin 1 ↑ | Inhibit cell viability and testosterone output, increase autophagic vacuoles and oxidative stress | Mouse Leydig TM3 cell line |
|
| SSCs | LC3-II/LC3-I, Atg5, Beclin 1 ↑ | Inhibit viability and proliferation of rat SSCs | Primary SSCs of rats |
| |
|
| Sertoli cells |
Beclin 1, p62↑ LC3, Atg5↓ | No significant morphological alterations | Primary Sertoli cells of mice |
|
| Leydig cells | LC3, Beclin 1, Atg5↑ | Increase autophagosomes number | Kunming mice |
| |
|
| Sertoli cells |
Beclin 1, Atg3/5/7/12↑ LC3-II/LC3-I↑ | Stimulate the formation of autophagosomes | Sprague Dawley rats |
|
|
| SSCs | LC3-II/LC3-I, Atg5, Beclin 1↑ | Decrease cell viability and increase autophagic vacuoles | Primary SSCs of rats |
|
|
| Leydig tumor cells | LC3, Atg7, Beclin 1, Vps34↑ | Impair lysosomes function and induce accumulation of autophagosomes | MLTC-1 |
|
|
| Leydig cells | LC3-II, Atg5, Beclin 1↑ | Disrupt seminiferous epithelium, decrease sperm density and serum testosterone levels | Kunming mice and TM3 cells |
|
|
| Sperm |
LC3-II, Beclin 1↑ p-mTOR/mTOR↓ | Reduce sperm count and motility, impair the seminiferous tubule, induce apoptosis and oxidative stress | Sprague Dawley rats |
|
|
| Leydig cells | Beclin 1, LC3B↑ | Induce serum testosterone reduction and more autophagosomes | C57BL/6 J mice and TM3 cells |
|
|
| SSCs | Beclin 1, LC3B↑ | Increase testicular organ coefficients, seminiferous tubular atrophy, SSCs falling off the inner lining, reduce germ cell layers of disorderly arrangements | Wistar rats |
|
| Spermotogonium, Sertoli/ Leydig cells, primary/second spermatocytes, GC-1/GC-2/TM3/TM4 cells |
Beclin 1, LC3-II/LC3-I↑ p-mTOR/mTOR ( | Reduce sperm count and motility, impair the seminiferous tubule, induce autophagy, apoptosis and oxidative stress | Sprague Dawley rats, GC-1/GC-2/TM3/TM4 cells |
| |
|
| Leydig cells | Beclin 1↑ | Suppress proliferation and viability of Leydig cells, decrease testosterone, stimulate autophagy | Primary Leydig cells of mice |
|
DEHP, di-2-ethyl hexyl phthalate; GC-1 cells, mouse spermatogonial cell lines; GC-2 cells, mouse spermatocyte cell lines; MLTC-1, mouse Leydig tumor cell lines; mTOR, mammalian target of rapamycin; SCOTP, saligenin cyclic-O-tolyl phosphate; SSCs, spermatogonial stem cells; TM3 cells, mouse Leydig cell lines; TM4 cells, mouse Sertoli cell lines; TOCP, tri-ortho-cresyl phosphate.
Figure 3.Role of autophagy in spermatogenesis. (a) Role of mTORC1 in spermatogenesis. mTORC1, the main gate to autophagy, is crucial for spermatogonia stem cell (SCCs) proliferation, differentiation, meiotic progression, inactivation of sex chromosomes and spermiogenesis. Firstly, proliferation of SSCs requires phosphorylation of the mTORC1 component Raptor at Ser863. Secondly, conditional ablation of Raptor causes infertility due to meiotic arrest and impaired inactivation of sex chromosomes in the male germline. Thirdly, Rheb, a critical component for mTORC1 activation, is required for meiotic progression and spermiogenesis. Consistently, retinoic acid (RA), as a requisite driver of spermatogonia differentiation and entrance into meiosis, regulates the PI3K/AKT/mTOR pathway to induce Kit translation during spermatogonial differentiation. In addition, Nanos2, an RNA-binding protein, interacts with mRNP to repress mTORC1 signaling by trapping mTOR, providing a post-transcriptional buffering system for SSCs homeostasis. Apart from germ cells, mTOR also plays a pivotal role in Sertoli cells. The regulation of Sertoli cell proliferation by FSH requires the PI3K/AKT/mTORC1 pathway. Independent of the canonical Rheb/mTORC1 pathway, Raptor dominates Sertoli cell cytoskeletal organization and polarity by affecting cingulin expression and Rac1 activity. Consistently, mTOR regulates gap junction alpha-1 (GJA1) distribution in Sertoli cells and is essential for progression through the pachytene spermatocyte stage. Finally, mTORC1 regulates spermatogenesis by inhibiting autophagy initiation and autophagosome nucleation. (b) Role of autophagy in spermiogenesis. In terms of the role of autophagy in spermiogenesis, autophagy-related genes participate in acrosome biogenesis, flagella assembly, head shaping and the removal of cytoplasm from elongating spermatids. 1. Acrosome biogenesis. TBC1D20 facilitates autophagy flux by its RAB1B GAP function, and regulates the formation of acrosome, which is a LRO. Sirt1 regulates spermiogenesis by stimulating autophagy. I. The depletion of Sirt1 disrupts LC3 and ATG7 deacetylation, provoking the redistribution of LC3 from the nucleus to the cytoplasm. II. Golgi-derived vesicles fail to recruit LC3. And III. nucleus-associated acrosomal vesicles are unable to recruit GOPC and PICK1. ATG7 not only partially targets GOPC to control acrosome biogenesis, but also motivates LC3, which initiates autophagy. 2. Flagella assembly, head shaping, cytoplasm removal. ATG7 is required for spermatozoa flagella biogenesis and cytoplasm removal during spermiogenesis. IFT20, as a Golgi transport protein, contributes to the formation of autophagosome by delivering ATG16L, and lysosome biogenesis by regulating the post-Golgi transport of acid hydrolases. SPEF2 is elementary for microtubule-mediated transport in axonemal CP assembly and sperm head shaping. IFT20 interacts with SPEF2 to regulate the flagella. The autophagy-lysosome pathway regulates spermatid differentiation by degrading PDLIM1 to facilitate cytoskeleton organization. LRO, lysosome-related organelle; GOPC, Golgi-associated PDZ- and coiled-coil motif-containing protein; PDLIM1, PDZ and LIM domain 1; SPEF2, sperm flagellar 2.
Figure 4.Role of autophagy in sperm maturation. (a) Sertoli cells. Cell-specific knockout of Atg5 or Atg7 results in spermatozoa with malformed heads and low motility. Through PDLIM1, autophagy not only affects bES to regulate BTB, but also mediates aES to handle cytoskeleton, governing spermatids movement and release during spermiation. In sperm: autophagy can affect sperm motility by inhibiting the fusion of autophagosome and lysosomes through the PI3K/Akt-dependent pathway in leucine-treated zebrafish. (b) Capacitation. ROS regulates autophagy by transcriptional and post-transcriptional regulation, including ROS-FOXO3-LC3/BNIP3-autophagy, ROS-NRF2-P62-autophagy, ROS-HIF1-BNIP3/NIX-autophagy and ROS-TIGAR-autophagy. Cholesterol efflux alters lipid raft stability during capacitation. PKA can stimulate protein phosphorylation and capacitation or acrosomal exocytosis by activating tyrosine kinase and/or inhibiting protein phosphatase. Nonetheless, so far, there is no direct evidence that autophagy participates in the process of capacitation. It may be a good potential target for exploring the molecular mechanisms in capacitation disruption-induced male infertility. PDLIM1, PDZ and LIM domain 1; aES, apical ectoplasmic specialization; bES, basal ectoplasmic specialization; BTB, blood–testis barrier.
Figure 5.Role of autophagy in fertilization. Autophagy regulates the acrosome reaction, PME and MOs clearance during fertilization. (a) Acrosome reaction. NAADP and the two-pore channel (TPC) protein 1 participate in the acrosome reaction by Ca2+ release in mammalian spermatozoa. TPC2 mediates mTORC1, which is the main gateway to autophagy; in turn, mTORC1 controls lysosomal Ca2+ release by TPC2. Autophagy may operate the acrosome reaction through TPCs. (b) PME and MOs clearance. Both autophagy and the ubiquitin-proteasome system contribute to PME and MOs after fertilization. In C. elegans, CPS-6 regulates PME, and LGG-1/LGG-2 (LC3 homologs) operate PME and MOs clearance by interacting with maternal autophagy and proteasome machinery upon fertilization; K63 chains-mediated autophagy may modulate PME and MOs clearance, and K48 chains may participate in MOs clearance. However, the crosstalk of K63 chains and K48 chains remains an enigma. In mice, fertilization-triggered autophagy regulates the development of mammalian early embryos by ATG5; this autophagic degradation process is dependent on the E3 ubiquitin ligases PARKIN and MUL1, mitochondrial outer membrane protein FIS1, autophagy adaptor p62 and PINK1 kinase. Ubiquitin is only related to MOs but not PME, despite the fact that autophagosomes degrade both of MOs and paternal mitochondria. Two potential roles of paternal MOs are that MOs provide membranes for autophagosome formation or MOs launch autophagy through the process of PME. Autophagy is not involved in PME after fertilization: in mice, maternal inheritance of mtDNA may be a passive process as a result of pre-fertilization sperm mtDNA elimination and uneven mitochondrial distribution in embryos. The actual situation awaits further research. PME, paternal mitochondrial elimination; MOs, membranous organelles; TPC, the two-pore channel; mtDNA, mitochondria DNA.
The clinical prospects of autophagy activators and inhibitors.
| Drugs | Diseases | Functions | Possible mechanism | In human/animal/cell model | Reference |
|---|---|---|---|---|---|
|
| |||||
|
| Breast cancer | Inhibits proliferation of the endoplasmic reticulum-positive MCF-7 cell line | Rapidly stimulate mTOR non-specifically after medium replacement | MCF-7 breast cancer cell line |
|
| Transplanted tumors | Inhibits tumor growth at any stage of development | – | – |
| |
| Pancreatic cancer | Regulates cell growth and cyclin D1 expression | Constitutively actives FRAP-p70s6K pathway and inhibits cyclin D1 expression | MiaPaCa-2 and Panc-1 human pancreatic cancer cells and a pancreatic cancer tissue sample |
| |
| Vascular disease | Reduces vascular inflammation | Suppresses macrophage proliferation | Mice |
| |
| Type 2 diabetes | Improves insulin resistance and hepatic steatosis | Enhances autophagy by the inhibition of mTOR pathway | T2DM rats |
| |
| Myotrophic lateral sclerosis | Reduces neuronal loss and TDP43 inclusions; expands regulatory T lymphocytes with slow progression in ALS patients | Activates autophagy | Four human NB cell lines (AS, NGP, BE2, and KCNR); mice carrying xenograft NB tumors |
| |
| Facial angiofibromas | Appears effective and safe for treatment of TSC-related facial angiofibromas | – | TB3 cells |
| |
| Improves ovarian function and reproductive longevity | – | – |
| ||
|
| Neuroblastoma | increases apoptosis and inhibits neuroblastoma tumor cell growth | Decreases AKT phosphorylation | Four human NB cell lines (AS, NGP, BE2, and KCNR); mice carrying xenograft NB tumors |
|
| Neuroblastoma | Attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance | Inhibits AKT | TB3 cells |
| |
|
| Glioblastoma | Inhibits growth of human glioblastoma cells and enhances therapeutic response | Activates AMPK, Redd1 and inhibits mTOR pathway | Four human glioblastoma cell lines, U87 (ATCC HTB-14), LN18 (ATCC CRL-2610), U251 and SF767 |
|
|
| Prostate tumors | Inhibits progression of prostatic intraepithelial neoplasia lesions to adenocarcinomas in the ventral prostate | Down-regulates mTORC1 signaling | HiMyc mice |
|
|
| Reproductive health, gynecological cancer | Inhibits progression of prostatic intraepithelial neoplasia lesions to adenocarcinomas in the ventral prostate | Upstream activation of AMPK, resulting in inhibition of the mTOR pathway. | HiMyc mice |
|
|
| |||||
|
| Pediatric B-cell acute lymphoblastic leukemia | Inhibits and kills pediatric B-cell acute lymphoblastic leukemia cells | Targets both autophagy and apoptosis by disassociating the Beclin 1–Vps34 complex | – |
|
| Microcephaly | Inhibits ZIKV entry and prevents the spread of the infection by interfering with viral maturation | Inhibits V-ATPase | – |
| |
| Tongue squamous cell carcinoma | Increases the sensitivity of tongue squamous cell carcinoma cells to cisplatin | Inhibition of the lysosomal uptake of platinum ions but not autophagy | – |
| |
|
| Breast cancer | Enhances the efficacy of tumor cell killing by combination with chemotherapeutic drugs and radiation | – | – |
|
| Colon cancer | Enhances the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle alteration | Anti-cancer effect of 5-FU via cell cycle inhibition | Human colon cancer DLD-1 cells |
| |
|
| Glioblastomas | Improves the efficacy of curcumin/temozolomide combination therapy | Increases apoptosis | C6, U251MG and U87MG cell lines; primary astrocytes |
|
| Malignant gliomas | Enhances temozolomide cytotoxicity | Blocks autophagy and triggers endoplasmic reticulum stress, increasing the chemosensitivity of glioma cells to temozolomide | Subcutaneously implanted U87MG tumors from mice |
| |
| Glioma | Potentiates temozolomide cytotoxicity | Inhibits mitochondrial autophagy | Tumor cells derived from a glioblastoma patient and human U87-MG glioblastoma cells |
| |
|
| Advanced solid tumors and melanoma | Augments cell death in preclinical models | Blocks autophagy | – |
|
|
| Breast cancer | Induces apoptosis via cathepsin D accumulation and enhances vorinostat-mediated cell death in breast cancer models. | Induces lysosomal membrane permeabilization | p53(+/+) and p53(−/−) HCT116 cells |
|
|
| Ovarian cancer | Enhances cisplatin-induced apoptosis | Activates PI3K/Akt signaling pathway | A2780 ovarian adenocarcinoma cell line and A2780cis |
|
3-MA, 3-methylade nine; AKT, protein kinase B; ALS, amyotrophic lateral sclerosis; AMPK, AMP-activated protein kinase; MCF-7 cells, human breast cancer cell lines; mTOR, mammalian target of rapamycin; NB tumor, neuroblastoma; T2DM rat, type 2 diabetes mellitus rat; TrkB, neurotrophic receptor tyrosine kinase 2; TSC, tuberous sclerosis complex; ZIKV, Zika virus.